Passage Bio Inc

General ticker "PASG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $46.4M

Passage Bio Inc does not follow the US Stock Market performance with the rate: -26.2%.

Estimated limits based on current volatility of 3.6%: low 0.63$, high 0.67$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Earnings for 6 months up through Q2 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.65$, 2.06$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.79$, 2.34$]

Financial Metrics affecting the PASG estimates:

  • Negative: Non-GAAP EPS, $ of -1.86 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -66.50 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term PASG quotes

Long-term PASG plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $185.73MM $138.39MM $108.39MM
Operating Income $-185.73MM $-138.39MM $-108.39MM
Non-Operating Income $0.34MM $2.27MM $6.33MM
R&D Expense $117.67MM $86.05MM $61.42MM
Income(Loss) $-185.39MM $-136.12MM $-102.06MM
Profit(Loss) $-185.39MM $-136.12MM $-102.06MM
Stockholders Equity $318.66MM $201.37MM $111.28MM
Assets $355.08MM $243.55MM $150.54MM
Operating Cash Flow $-126.88MM $-118.21MM $-78.26MM
Capital expenditure $25.64MM $5.27MM $0.15MM
Investing Cash Flow $-45.81MM $25.20MM $65.24MM
Financing Cash Flow $166.66MM $-1.35MM $0.14MM
Earnings Per Share* $-3.59 $-2.51 $-1.86

* EPS are Split Adjusted, recent splits may be reflected with a delay.